Bellevue Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-52
| Closed | -$2.11K | – | 473 |
|
|
2023
Q2 | $2.11K | Hold |
52
| – | – | ﹤0.01% | 402 |
|
|
2023
Q1 | $2.52K | Hold |
52
| – | – | ﹤0.01% | 383 |
|
|
2022
Q4 | $1.93K | Hold |
52
| – | – | ﹤0.01% | 404 |
|
|
2022
Q3 | $3K | Hold |
52
| – | – | ﹤0.01% | 364 |
|
|
2022
Q2 | $2K | Hold |
52
| – | – | ﹤0.01% | 428 |
|
|
2022
Q1 | $2K | Sell |
52
-14
| -21% | -$538 | ﹤0.01% | 471 |
|
|
2021
Q4 | $3K | Sell |
66
-6
| -8% | -$273 | ﹤0.01% | 457 |
|
|
2021
Q3 | $3K | Hold |
72
| – | – | ﹤0.01% | 474 |
|
|
2021
Q2 | $3K | Sell |
72
-8
| -10% | -$333 | ﹤0.01% | 465 |
|
|
2021
Q1 | $4K | Sell |
80
-6
| -7% | -$300 | ﹤0.01% | 471 |
|
|
2020
Q4 | $5K | Sell |
86
-19
| -18% | -$1.11K | ﹤0.01% | 431 |
|
|
2020
Q3 | $5K | Hold |
105
| – | – | ﹤0.01% | 399 |
|
|
2020
Q2 | $5K | Hold |
105
| – | – | 0.01% | 400 |
|
|
2020
Q1 | $6K | Buy |
105
+51
| +94% | +$2.91K | 0.01% | 374 |
|
|
2019
Q4 | $3K | Buy |
+54
| New | +$3K | ﹤0.01% | 399 |
|